Cargando…
Clinical value of MLH1-negative circulating tumor cells in lung cancer patients
Circulating tumor cells (CTCs) serve as valuable biomarkers. However, MutL homolog 1 (MLH1)-negative CTCs and their clinical significance in lung cancer are nearly unknown. Here, bioinformatic analysis of MLH1 expression and its clinical significance was conducted using the Oncomine, Ualcan, and Kap...
Autores principales: | Liang, Jin-Yan, Yang, Qi-Fan, Zeng, Yu-Lan, Liu, Yang-Yang, Liu, Yu-Ting, Gu, Fei-Fei, Hu, Yue, Zhang, Kai, Zhong, Hao, Liu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636948/ https://www.ncbi.nlm.nih.gov/pubmed/31232917 http://dx.doi.org/10.1097/MD.0000000000015721 |
Ejemplares similares
-
The Superior Ability of Human BDCA3(+) (CD141(+)) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
por: Gu, Fei-fei, et al.
Publicado: (2020) -
Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report
por: Liang, Jin-Yan, et al.
Publicado: (2017) -
Association between MLH1 -93G>A Polymorphism and Risk of Colorectal Cancer
por: Wang, Ting, et al.
Publicado: (2012) -
MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway
por: Li, Yue, et al.
Publicado: (2018) -
Linker domain function predicts pathogenic MLH1 missense variants
por: London, James, et al.
Publicado: (2021)